Luminex, University of São Paulo Collaborate on Zika Virus Detection Panel Validation | GenomeWeb https://t.co/cwLhKzUztV
7:45pm February 26th 2016 via Hootsuite
I’m a high-risk pregnancy expert. So why didn’t I worry about my own fertility? - The Washington Post https://t.co/lwHCwZ0pr4
6:10pm February 26th 2016 via Hootsuite
Science Fairs Have Lost Their Way. Let’s Make Them Cool Again | WIRED https://t.co/QXbrwwyIIa
5:45pm February 26th 2016 via Hootsuite
Intel hops on the precision medicine bandwagon with new projects for 2016 - FierceMedicalDevices https://t.co/DwYx4pUm0d
5:22pm February 26th 2016 via Hootsuite
RT @NatureNews: What are your tech predictions for #futuregenerations? https://t.co/66Ankw9UrE https://t.co/6QTcQYcPrg
4:10pm February 26th 2016 via Hootsuite
Understanding the links between privacy and public data sharing. - PubMed https://t.co/OurX6HG8LC
1:50pm February 26th 2016 via Hootsuite
RT @NatureNews: Fight brews over promising 'nanopore' genetic-sequencing technology https://t.co/b8bFHGuJ7u https://t.co/xsLbYbkPjQ
12:10pm February 26th 2016 via Hootsuite
RT @ACGT_blog: New post: How would you describe genomics without using any scientific jargon? https://t.co/NRkBALzVjV
11:30am February 26th 2016 via Hootsuite
CoreGenomics: Longitudinal monitoring of tumour burden with a modified Guthrie card https://t.co/TEjKYqlzOf
10:50am February 26th 2016 via Hootsuite
First PrecisionFDA Challenge Seeks Pipelines for Variant Call Comparisons | GenomeWeb https://t.co/hg69vQhesZ
9:55am February 26th 2016 via Hootsuite
Bio-Rad Q4 Revenues Fall 5 Percent; Firm Gets CE IVD Mark for Droplet Digital PCR System | GenomeWeb https://t.co/lMxLpss5nR
8:55am February 26th 2016 via Hootsuite
Genomic analyses identify molecular subtypes of pancreatic cancer. - PubMed https://t.co/gJ5Khni01Q
7:10am February 26th 2016 via Hootsuite
White House Announces Efforts to Accelerate Precision Medicine Initiative | GenomeWeb https://t.co/gyYlCuNtxl
6:35am February 26th 2016 via Hootsuite
Feb 26 Friday noon ET / 5 GMT NGS Oncology Panels and the FDA Webinar | TOMABio @SeraCare https://t.co/EQuOFh5TFt
5:20am February 26th 2016 via Hootsuite
Opening a window of opportunity for head and neck cancer — Medium https://t.co/6q9Jb0zPsV
10:35pm February 25th 2016 via Hootsuite
The Step-By-Step Guide To Getting Famous On Social Media — Medium https://t.co/4W691Ehtvx
9:35pm February 25th 2016 via Hootsuite
This is the least useful passport to carry around the world - The Washington Post https://t.co/Qwd9zgCi9S
9:30pm February 25th 2016 via Hootsuite
Alipay is 73% of China's mobile transactions. How Mobile Payments Reshape Lifestyles - WSJ https://t.co/G4smL1nz0V
8:05pm February 25th 2016 via Hootsuite
Verily tapped by NIH to launch Obama's Precision Medicine Initiative - FierceMedicalDevices https://t.co/vRWVWj9VEH
6:40pm February 25th 2016 via Hootsuite
RT @DaleYuzuki: Register for Friday's noon ET / 5 GMT NGS Oncology Panels and the FDA Webinar | TOMABio @SeraCare https://t.co/EQuOFh5TFt
4:05pm February 25th 2016 via Hootsuite
Kulkarni: Inpt work with ClinGen, important to build database of variants expertly curated. #FDANGSWorkshop
1:41pm February 25th 2016 via Hootsuite
Kulkarni: Huge challenges w/databases; cell lines w/issues (gain aneuploidy or other artifacts). #FDANGSWorkshop
1:40pm February 25th 2016 via Hootsuite
Kulkarni: L5 is a known SNP (ESP, ExAC, TGP w/MAF >1%) #FDANGSWorkshop
Kulkarni: Leve 1: predictive, prognostic (BRAF V600E); L2 in other tumor types (IDH1 in CRC) L3: Reported (unk sig) L4: VUS #FDANGSWorkshop
1:39pm February 25th 2016 via Hootsuite
Kulkarni: AMP and ACMG and ASCO have joint committees for giving guidelines 'in a few months' #FDANGSWorkshop
1:38pm February 25th 2016 via Hootsuite
Great to meet @VanAllenLab IRL at the #FDANGSWorkshop today. Live-tweeting has its rewards!!
1:37pm February 25th 2016 via Hootsuite
RT @kennamshaw: Shashi Kulkarni from wash u speaks first on clinical interpretation/signifiance of variants #FDA #NGS #FDANGSWorkshop
1:36pm February 25th 2016 via Hootsuite
RT @kennamshaw: Shashi Kulkarni from wash u speaks first on clinical interpretation/signifiance of variants #FDA #NGS
1:35pm February 25th 2016 via Hootsuite
.@VanAllenLab Glad my 'open notebook' could be of help!
12:00pm February 25th 2016 via Hootsuite in reply to VanAllenLab
Rossi: 'We use genomics to get at biology' Aisner: Rather than tumor types, should look at matrix interference as well #FDANGSWorkshop
10:17am February 25th 2016 via Hootsuite
Luthra: Their experience (MDA) has been not tumor type, but rather how it was prepared (FNA or resection) and FF or FFPE #FDANGSWorkshop
10:14am February 25th 2016 via Hootsuite
Philip: Even sequencing platform differences, and effect on analytical validation #FDANGSWorkshop
9:02am February 25th 2016 via Hootsuite
Philip: And what validation needed to support claims. And analytical validation and bioinf: from CDx to VUS Q's on validity #FDANGSWorkshop
8:58am February 25th 2016 via Hootsuite
Philip: Seeking input on Pre-analytical and Quality Metric approaches. Which steps most critical? What tissue types hard? #FDANGSWorkshop
8:57am February 25th 2016 via Hootsuite
Philip: In Table 2: Include tissue types? What level of clin validity outside tables 1/2? Invites feedback to docket #FDANGSWorkshop
8:56am February 25th 2016 via Hootsuite
Philip: #FDANGSWorkshop Discussion paper PDF: https://t.co/HfazwulstZ has intended use statement. Table 2 intended use generates add'l Q's
8:54am February 25th 2016 via Hootsuite
Philip: Questions: what genes / vars to include? Limits of reporting? Matching blood? Units of validation? Difficult units? #FDANGSWorkshop
8:51am February 25th 2016 via Hootsuite
Philip: Entire system validation - from collection through generation of reporting; all performance char's #FDANGSWorkshop
8:50am February 25th 2016 via Hootsuite
Philip: Hypothetical case: 10-gene NGS panel; 5 CDx genes, DNA/RNA 100 SNVs, 10 indels, 50 fusions, 10 CNVs. CRC and NSCLC #FDANGSWorkshop
Philip: Intended use: CDx and alternative Rx. Today doesn't cover ctDNA (July 19th planned). No WES/WGS, carrier screening #FDANGSWorkshop
8:48am February 25th 2016 via Hootsuite
Philip: Today's goals: obtain stakeholder input to establ. performance char's for rare variant types; labeling, performance #FDANGSWorkshop
8:47am February 25th 2016 via Hootsuite
Philip: PDF of CDx guideline here: ://ow.ly/YK7Hv Reviews Clinical utility, validity. CDx to-date has been single-analyte #FDANGSWorkshop
8:45am February 25th 2016 via Hootsuite
Reena Philip starts #FDANGSWorkshop with a discussion of Personalized Med and companion diagnostic's role. CDx guidelines Aug 2014
8:42am February 25th 2016 via Hootsuite
#FDANGSWorkshop Begins - Next Gen Sequencing-Based Oncology Panels, 2/25/16 https://t.co/d06mPZl5bO https://t.co/cM51DzNfma
8:36am February 25th 2016 via Hootsuite
RT @atulbutte: Wow! Inova Health unveils $100 million venture fund focused on #precisionmedicine! https://t.co/Xefjk54eT1
7:45am February 25th 2016 via Hootsuite
Illumina Sues Oxford Nanopore Technologies Over Composition of Nanopores - Bio-IT World https://t.co/XN444FyVV8
6:50am February 25th 2016 via Hootsuite
Register for Friday's noon ET / 5 GMT NGS Oncology Panels and the FDA Webinar | TOMABio @SeraCare https://t.co/EQuOFh5TFt
5:15am February 25th 2016 via Hootsuite
RT @Clive_G_Brown: With Patent Suit, Illumina Looks to Tame Emerging British Rival, Oxford Nanopore https://t.co/V3VICiYP7E
4:27am February 25th 2016 via Hootsuite
RT @pickover: First-Place Science Project. https://t.co/Tww2FO6ZEs
9:03pm February 24th 2016 via Hootsuite
Google's Verily, Dexcom aim to launch mini glucose monitor in 2018, with next-gen by 2021 - FierceMedicalDevices https://t.co/PkuTogACvS
8:15pm February 24th 2016 via Hootsuite
